A new dimension in newborn screening.

to improve newborn health.

Newborn screening is a key paediatrics’ tool for early detection of treatable congenital diseases. Introduction of a genomic newborn screening program could significantly improve detection and treatment of critical pediatric diseases. .

9 communities

Pilot project is taking place in Andalucía, Aragón, Asturias, Cataluña, Galicia, La Rioja, Madrid, Murcia y Valencia.

80%

Over 80% of rare diseases have a genetic origin.

44 diseases

Traditional screening in Spain detects between 11 and 44 diseases

We are more than

70

specialists

We can detect more than

300

rare diseases

Sequencing analysis
will allow studying more

600

Genes

What is CRINGENES?

A key tool in detecting paediatric diseases before symptoms appear.

Traditional screening detects between 11 and 44 diseases. Through genomic analysis this limit could be surpassed since 80% of all rare diseases have a genetic origin.

Explore the Project

Get to know the people, the data, and the advances that make this project possible.

CRINGENES brings together professionals from all over Spain, analyses hundreds of genes linked to rare diseases and shares its results with the scientific community. A pioneering initiative that combines science, health, and prevention starting at birth.

Transforming prevention into health from day one.

CRINGENES brings together professionals from all over Spain, analyses hundreds of genes linked to rare diseases and shares its results with the scientific community. A pioneering initiative that combines science, health, and prevention starting at birth.